Drug intelligence / Profile preview

carpronium chloride

Development stage
Unknown
Lead developer
Daiichi Sankyo Healthcare
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Carpronium chloride is a synthetic quaternary ammonium compound and a direct-acting muscarinic acetylcholine receptor agonist. Originally developed in Japan by Daiichi Pharmaceutical, it is primarily used as a topical hair growth stimulant to treat various forms of alopecia, including alopecia areata and androgenetic alopecia, as well as vitiligo vulgaris and seborrhea sicca. By mimicking parasympathetic activity, carpronium chloride dilates local capillaries and enhances blood circulation in the scalp, thereby improving nutrient and oxygen delivery to hair follicles and promoting hair regrowth. It is marketed in Japan under brand names such as Furozin and the over-the-counter Caloyan series. An oral formulation was historically marketed under the brand name Actinamin for the treatment of gastroptosis, but has since been discontinued.

Brand names
ActinaminCaloyanFroginFurozin
Other names
(3-carboxypropyl)trimethylammonium chloride methyl ester(4-methoxy-4-oxobutyl)-trimethylazanium chloride3-carboxy-N,N,N-trimethyl-1-propanaminium chloride methyl estercarpronium chloride hydratecloruro de carproniog-butyrobetaine chloride methyl estermethyl N-trimethyl-g-aminobutyrate chlorideカルプロニウム塩化物
02

Targets

CHRM2 (Muscarinic acetylcholine receptor M2)CHRM3 (M3)CHRM4 (M4)CHRM5 (M5)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on carpronium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carpronium chloride.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call